Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +742.52%
#3 ADO Protocol ADO Protocol +101.52%
#4 Cortex Cortex +93.35%
#5 Ontology Gas Ontology Gas +69.13%
#6 Kinesis Silver Kinesis Silver +53.14%
#7 OpenEden OpenEden +36.68%
#8 Magma Finance Magma Finance +27.83%
#9 Ontology Ontology +25.97%
#10 QuantixAI QuantixAI +23.21%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Simcere Pharmaceutical Group Limited Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited

2096
Classificação em ações #4368
Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the... Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the comprehensive process of discovering, developing, manufacturing, and commercializing pharmaceutical products. These medicines are distributed to various clients, including distributors, pharmacy chains, and fellow drug manufacturers within China. The company strategically focuses on a diverse range of therapeutic areas, notably oncology, central nervous system conditions, autoimmune diseases, anti-infective treatments, and cardiovascular health, among others. Its extensive product portfolio features key medications such as Sanbexin (an edaravone and dexborneol concentrated solution for injection), Endostar (a recombinant human endostatin injection), ENWEIDA (an envafolimab injection), Softan (rosuvastatin calcium tablets), ZAILIN (amoxicillin in granules, dispersible tablets, or capsules), Iremod (iguratimod tablets), Antine (diclofenac sodium sustained-release capsules or gel), and Orencia (an abatacept injection). Additionally, Simcere offers specialized promotional services for pharmaceutical goods. Demonstrating its commitment to innovation, the group has established a strategic regional licensing collaboration with Vivoryon Therapeutics N.V. This partnership aims to develop and commercialize novel therapies for Alzheimer's disease by targeting the neurotoxic amyloid protein N3pE (pGlu-Aß). Established in 1995, Simcere Pharmaceutical Group Limited is headquartered in Nanjing, China.
Preço da ação
$1.48
Valor de mercado
$3.81B
Variação (1 dia)
0.61%
Variação (1 ano)
-19.90%
País
CN
Negociar Simcere Pharmaceutical Group Limited (2096)

Categoria

Healthcare
Histórico de preços das ações de Simcere Pharmaceutical Group Limited (2096)
Preço de fecho mais alto: $1.55 em 2026-08-01

Preço de fecho mais baixo: $1.42 em 2020-10-01
Histórico de preços das ações da Simcere Pharmaceutical Group Limited de 2020 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -6.51%
2025 86.13%
2024 5.24%
2023 -33.80%
2022 10.61%
2021 9.90%
2020 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.89%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 48.99%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.62 -12.98%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.86 489.81%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 6.25%
CH